Sign In
Buy RDY
$13.02
-0.0100 (-0.0767%)
At Close: Jun 03, 2026
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY
12:18am, Tuesday, 02'nd Feb 2021
NEW YORK, Feb. 2, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Dr. Reddy's Laboratories Limited ("Dr. Reddy's" or the "Company") (NYSE: RDY). Such investors are
Dr. Reddy's (RDY) Q3 Earnings Decline Y/Y, Sales Increase
11:22am, Monday, 01'st Feb 2021
Dr. Reddy's (RDY) earnings decline while sales grow year over year in third-quarter fiscal 2021.
Dr. Reddy's Laboratories Limited (RDY) CEO Erez Israeli on Q3 2021 Results - Earnings Call Transcript
10:59pm, Friday, 29'th Jan 2021
Dr. Reddy's Laboratories Limited (RDY) CEO Erez Israeli on Q3 2021 Results - Earnings Call Transcript
Dr. Reddy's Q3 & 9M FY21 Financial Results
04:37am, Friday, 29'th Jan 2021
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) today announced its consolidated financial results for the quarter and the
Dr. Reddy's (RDY) Ends Kuwait Study on Avigan for COVID-19
11:17am, Thursday, 28'th Jan 2021
Dr. Reddy's (RDY) and Global Response Aid FZCO terminate the Avigan study conducted in Kuwait, focused on moderate-to-severe COVID patients in a hospital setting.
Dr. Reddy's and GRA Announce Clinically Meaningful Data from Avigan Pivotal Studies
02:12pm, Wednesday, 27'th Jan 2021
KUWAIT CITY, Jan. 27, 2021 /PRNewswire/ -- Dr. Reddy's Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) (NSEIFSC: DRREDDY along with its subsidiaries together referred to as "Dr. Reddy's") a
Dr. Reddy's and GRA announces Avigan Pivotal Studies Update
05:02am, Wednesday, 27'th Jan 2021
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY along with its subsidiaries together referred to as “Dr. Reddy's”) and Glob
Dr. Reddy's (RDY) to Begin Phase III Study on Sputnik Vaccine
10:32am, Monday, 18'th Jan 2021
Dr. Reddy's (RDY) receives approval from the DCGI to conduct a phase III study on the Sputnik V vaccine for the treatment of COVID-19 in India.
Dr. Reddy's Receives Approval to Conduct Phase 3 Clinical Trial for Sputnik V Vaccine in India
12:33pm, Friday, 15'th Jan 2021
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) announced today that it has received approval from the Drugs Control General of
Dr. Reddy's Laboratories announces the launch of Febuxostat Tablets in the U.S. Market
04:59am, Monday, 11'th Jan 2021
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. R
Dr. Reddy's to Release Q3 FY 21 Results on January 29th, 2021
08:21am, Friday, 08'th Jan 2021
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) will announce results for the third quarter ended December 31, 2020 on Friday,
4 Emerging Market Stocks to Tap 2021 Economic Rebound
11:17am, Monday, 28'th Dec 2020
Here we discuss four emerging market stocks, BCAUY, BIDU, IMPUY and RDY, which have solid growth prospects for 2021.
Bernstein Favors India's Cipla, Dr. Reddy's, Sun Pharma, Lupin
12:31am, Thursday, 17'th Dec 2020
Dec.16 -- Nithya Balasubramanian, health-care analyst at Bernstein, discusses the prospects for Covid-19 vaccine approvals in India, and the outlook for the country's pharmaceutical industry. She spea
Secondary Listing of Dr. Reddy's ADRs on NSE IFSC Limited (GIFT City, Gujarat, India)
04:20am, Wednesday, 09'th Dec 2020
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY referred to as “Dr. Reddy's”) today announced the secondary listing of its
Dr. Reddy's and RDIF commence clinical trials for Sputnik V vaccine in India
08:15am, Tuesday, 01'st Dec 2020
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), and Russian Direct Investment Fund (RDIF) announced today that they have commenced adaptive pha
